Principle Health Systems Acquires Telos PGX
December 9, 2024
Principle Health Systems has acquired Telos PGX, a CLIA/COLA pharmacogenetic testing provider focused on the long-term care market. The acquisition adds pharmacogenetic testing capabilities to Principle's mobile diagnostic services and will keep Telos founder D.J. Hart in a leadership role to scale operations and expand PGx adoption in skilled nursing facilities.
- Buyers
- Principle Health Systems
- Targets
- Telos PGX
- Industry
- Healthcare Services
- Location
- Texas, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Principle Health Systems Acquires Heartland Health Laboratory
April 22, 2025
Healthcare Services
Principle Health Systems (PHS) has acquired Heartland Health Laboratory, a CLIA-certified, high-complexity clinical diagnostics lab based near Kansas City. The acquisition expands PHS's mobile diagnostic footprint in the Midwest and will involve investment in Heartland's team, technology and operations; the seller is Heartland owner Elizabeth Kent.
-
Labcorp Acquires Personal Genome Diagnostics (PGDx)
February 21, 2022
Healthcare Services
Labcorp completed its acquisition of Personal Genome Diagnostics (PGDx), a cancer genomics company that develops liquid biopsy and tissue-based NGS products. Labcorp paid $450 million in cash at closing plus up to $125 million in performance-based milestones to expand its oncology genomics and liquid biopsy capabilities and accelerate access to precision diagnostics for clinical care and trials.
-
healthŌme Acquires Kailos Genetics
May 31, 2023
Biotechnology
healthŌme Inc. has acquired Kailos Genetics, a CLIA-certified and CAP-accredited genetic testing laboratory, making Kailos a wholly-owned subsidiary to expand healthŌme's genomics testing capabilities. The deal integrates Kailos' laboratory facilities, proprietary sequencing workflow and reagent supply capabilities into healthŌme's precision health management platform, expanding distribution into life and critical illness insurance channels and broader healthcare and life-science markets.
-
Castle Biosciences Acquires AltheaDx
April 26, 2022
Healthcare Services
Castle Biosciences (Nasdaq: CSTL) completed the acquisition of AltheaDx, a San Diego-based commercial-stage pharmacogenomics company and maker of the IDgenetix mental-health PGx test. Castle paid $65.0 million in initial consideration (split $32.5M cash and $32.5M stock) and may pay up to an additional $75.0 million tied to performance and milestone achievements; AltheaDx becomes a wholly owned subsidiary and IDgenetix now has expanded Medicare coverage for multiple mental health conditions.
-
NeoGenomics Acquires Pathline
April 7, 2025
Healthcare Services
NeoGenomics, Inc. (NASDAQ: NEO) has completed its acquisition of Pathline, LLC, a CLIA/CAP/NYS-certified pathology laboratory headquartered in Ramsey, New Jersey. The deal strengthens NeoGenomics' commercial presence in the Northeast United States and expands its molecular and hematology-oncology testing capabilities and access to its oncology test menu.
-
Principle Health Systems Acquires BioStat Imaging
August 26, 2024
Healthcare Services
Principle Health Systems, a Houston-based provider of mobile laboratory services for long-term care facilities, has acquired BioStat Imaging, a mobile imaging provider based in Dallas, Texas. The acquisition expands Principle's diagnostic capabilities by adding mobile imaging to its laboratory services and introduces a unified customer portal to deliver lab and imaging results in one place.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.